0001606498-19-000027.txt : 20190506 0001606498-19-000027.hdr.sgml : 20190506 20190506154159 ACCESSION NUMBER: 0001606498-19-000027 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190425 FILED AS OF DATE: 20190506 DATE AS OF CHANGE: 20190506 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ball David Edward CENTRAL INDEX KEY: 0001775747 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36440 FILM NUMBER: 19799168 MAIL ADDRESS: STREET 1: AVANOS MEDICAL, INC., 5405 WINDWARD PKWY CITY: ALPHARETTA STATE: 2Q ZIP: 30004 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Avanos Medical, Inc. CENTRAL INDEX KEY: 0001606498 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 464987888 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5405 WINDWARD PARKWAY CITY: ALPHARETTA STATE: GA ZIP: 30004 BUSINESS PHONE: 678-425-9273 MAIL ADDRESS: STREET 1: 5405 WINDWARD PARKWAY CITY: ALPHARETTA STATE: GA ZIP: 30004 FORMER COMPANY: FORMER CONFORMED NAME: Halyard Health, Inc. DATE OF NAME CHANGE: 20140424 3 1 wf-form3_155717170414838.xml FORM 3 X0206 3 2019-04-25 0 0001606498 Avanos Medical, Inc. AVNS 0001775747 Ball David Edward 5405 WINDWARD PKWY ALPHARETTA GA 30004 0 1 0 0 SVP - Global Supply Chain Common Stock 47.59 2021-12-17 2028-12-17 Common Stock 4728.0 D Represents time-vested restricted stock units issued on December 17, 2018, with a 3 year cliff vesting period. Exhibit 24 - Power of Attorney /s/ Ross Mansbach, as attorney-in-fact for David Edward Ball 2019-05-06 EX-24 2 poa-ball.htm POWER OF ATTORNEY

POWER OF ATTORNEY

    KNOW ALL MEN BY THESE PRESENTS, that the undersigned does hereby constitute and
appoint John W. Wesley, S. Ross Mansbach and Jacob D. Robinson, and each of
them, with full power to act alone, his true and lawful attorney-in-fact and
agent, with full power of substitution and resubstitution, for his and in his
name, place and stead, in any and all capacities, to execute and acknowledge
Form 144 under the Securities Act of 1933, as amended (the "Securities Act"),
and Rule 144 thereunder, and Forms 3, 4 and 5 pursuant to Section 16(a) of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the rules
and regulations thereunder, any amendments to such forms, and any and all other
documents (and amendments thereto), including, without limitation, Form ID,
necessary or desirable to facilitate the filing by the undersigned of Form 144
and forms under Section 16(a) of the Exchange Act, with respect to securities of
Avanos Medical, Inc. (the "Company"), and to deliver and file the same with all
exhibits thereto, and all other documents in connection therewith, to and with
the Securities and Exchange Commission, the national securities exchanges and
the Company, granting unto said attorneys in fact and agents, and each of them,
full power and authority to do and perform each and every act and thing
requisite and necessary to be done, as fully to all intents and purposes as the
undersigned might or could do in person, hereby ratifying and confirming all
that said attorneys in fact and agents or any one of them, or his or her
substitute or their substitutes, lawfully do or cause to be done by virtue
hereof.  The undersigned agrees that each of the attorneys in fact herein may
rely entirely on information furnished orally or in writing by the undersigned
to such attorney-in-fact.

    The validity of this Power of Attorney shall not be affected in any manner by
reason of the execution, at any time, of other powers of attorney by the
undersigned in favor of persons other than those named herein.

    This Power of Attorney shall continue in full force and effect until the
undersigned is no longer required to file Form 3, Form 4, Form 5 or Form 144
with regard to the undersigned's ownership of or transactions in securities of
the Company, unless earlier revoked in writing.  The undersigned acknowledges
that the foregoing attorneys-in-fact are not assuming any of the undersigned's
responsibilities to comply with Rule 144 under the Securities Act or Section 16
of the Exchange Act.

    IN WITNESS WHEREOF, I have hereunto set my hand effective this 30th day of
April, 2019.


/s/ David Edward Ball
David Edward Ball